[go: up one dir, main page]

SE9002480D0 - Assay of free and complexed prostate-specific antigen - Google Patents

Assay of free and complexed prostate-specific antigen

Info

Publication number
SE9002480D0
SE9002480D0 SE9002480A SE9002480A SE9002480D0 SE 9002480 D0 SE9002480 D0 SE 9002480D0 SE 9002480 A SE9002480 A SE 9002480A SE 9002480 A SE9002480 A SE 9002480A SE 9002480 D0 SE9002480 D0 SE 9002480D0
Authority
SE
Sweden
Prior art keywords
psa
free
assay
specific antigen
complex
Prior art date
Application number
SE9002480A
Other languages
English (en)
Inventor
Hans Lilja
Ulf-Haakan Stenman
Original Assignee
Hans Lilja
Ulf Haakan Stenman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20380033&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9002480(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hans Lilja, Ulf Haakan Stenman filed Critical Hans Lilja
Priority to SE9002480A priority Critical patent/SE9002480D0/sv
Publication of SE9002480D0 publication Critical patent/SE9002480D0/sv
Priority to DK91913019T priority patent/DK0540573T4/da
Priority to US07/956,509 priority patent/US5501983A/en
Priority to JP3512776A priority patent/JP2669566B2/ja
Priority to DE0540573T priority patent/DE540573T1/de
Priority to DE69117292T priority patent/DE69117292T3/de
Priority to AT91913019T priority patent/ATE134448T1/de
Priority to EP91913019A priority patent/EP0540573B2/en
Priority to DE9117047U priority patent/DE9117047U1/de
Priority to PCT/FI1991/000223 priority patent/WO1992001936A1/en
Priority to ES91913019T priority patent/ES2070107T5/es
Priority to US08/446,526 priority patent/US5939533A/en
Priority to US08/480,708 priority patent/US5912158A/en
Priority to GR960401268T priority patent/GR3019888T3/el
Priority to US09/905,998 priority patent/US20020123616A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G01N33/57525—

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9002480A 1990-07-23 1990-07-23 Assay of free and complexed prostate-specific antigen SE9002480D0 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE9002480A SE9002480D0 (sv) 1990-07-23 1990-07-23 Assay of free and complexed prostate-specific antigen
PCT/FI1991/000223 WO1992001936A1 (en) 1990-07-23 1991-07-22 Assay of free and complexed prostate-specific antigen (psa)
ES91913019T ES2070107T5 (es) 1990-07-23 1991-07-22 Ensayo de antigeno especifico de la prostata (psa) libre y complejado.
DE69117292T DE69117292T3 (de) 1990-07-23 1991-07-22 Bestimmung von freiem und komplexiertem prostata-spezifischem antigen
DE9117047U DE9117047U1 (de) 1990-07-23 1991-07-22 Assay für freies und komplexiertes Prostata-spezifisches Antigen
JP3512776A JP2669566B2 (ja) 1990-07-23 1991-07-22 遊離及び複合体形成した前立腺特異的抗原（ｐｓａ）の分析
DE0540573T DE540573T1 (de) 1990-07-23 1991-07-22 Bestimmung von freiem und komplexiertem prostat-spezifisches antigen.
DK91913019T DK0540573T4 (da) 1990-07-23 1991-07-22 Assay for frit- og kompleksbundet prostataspecifikt antigen (PSA)
AT91913019T ATE134448T1 (de) 1990-07-23 1991-07-22 Bestimmung von freiem und komplexiertem prostat- spezifisches antigen
EP91913019A EP0540573B2 (en) 1990-07-23 1991-07-22 Assay of free and complexed prostate-specific antigen (psa)
US07/956,509 US5501983A (en) 1990-07-23 1991-07-22 Assay of free and complexed prostate-specific antigen
US08/446,526 US5939533A (en) 1990-07-23 1995-05-19 Assay of free and complexed prostate-specific antigen (PSA)
US08/480,708 US5912158A (en) 1990-07-23 1995-06-07 Prostate specific antigen (PSA)-proteinase inhibitor complexes
GR960401268T GR3019888T3 (en) 1990-07-23 1996-05-13 Assay of free and complexed prostate-specific antigen (psa)
US09/905,998 US20020123616A1 (en) 1990-07-23 2001-07-17 Prostate specific antigen (PSA) -proteinase inhibitors complexes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002480A SE9002480D0 (sv) 1990-07-23 1990-07-23 Assay of free and complexed prostate-specific antigen

Publications (1)

Publication Number Publication Date
SE9002480D0 true SE9002480D0 (sv) 1990-07-23

Family

ID=20380033

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9002480A SE9002480D0 (sv) 1990-07-23 1990-07-23 Assay of free and complexed prostate-specific antigen

Country Status (10)

Country Link
US (4) US5501983A (sv)
EP (1) EP0540573B2 (sv)
JP (1) JP2669566B2 (sv)
AT (1) ATE134448T1 (sv)
DE (2) DE540573T1 (sv)
DK (1) DK0540573T4 (sv)
ES (1) ES2070107T5 (sv)
GR (1) GR3019888T3 (sv)
SE (1) SE9002480D0 (sv)
WO (1) WO1992001936A1 (sv)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965379A (en) * 1991-07-19 1999-10-12 Cytimmune Sciences Inc. Method for measuring endogenous cytokines
GB9309966D0 (en) * 1993-05-14 1993-06-30 Nordion Int Inc Detection of prostrate-specific antigen in breast tumors
GB9314623D0 (en) * 1993-07-14 1993-08-25 Nordion Int Inc Localization and therapy with agents directed against prostate specific antigen in breast cancer
EP0635575A1 (en) 1993-07-22 1995-01-25 Wallac Oy Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen
EP0652014A1 (en) * 1993-11-10 1995-05-10 National Institute Of Immunology Treatment of prostatic hypertrophy
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5599686A (en) * 1994-06-28 1997-02-04 Merck & Co., Inc. Peptides
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
GB9415489D0 (en) * 1994-08-01 1994-09-21 Nordion Int Inc Detection of prostate-specific antigen in amniotic fluid
EP0725139A3 (en) * 1995-02-03 1997-11-26 Bayer Corporation Recombinant prostate-specific antigen and its use as an immunoassay calibrator
US5698402A (en) * 1995-02-23 1997-12-16 Dianon Systems, Inc. Methods for diagnosing benign prostatic hyperplasia
US5614372A (en) * 1995-02-24 1997-03-25 Lilja; Hans Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)
US5654161A (en) * 1995-05-12 1997-08-05 Chiron Diagnostics Corporation Method for diagnosing prostate cancer
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
WO1997009925A2 (en) * 1995-09-12 1997-03-20 The General Hospital Corporation Method for early detection of ovarian cancer
US5800347A (en) * 1995-11-03 1998-09-01 The General Hospital Corporation ROC method for early detection of disease
US5710007A (en) * 1995-09-29 1998-01-20 Luderer; Albert A. Methods for diagnosing prostatic adenocarcinoma
EP0855910A4 (en) * 1995-10-18 2000-07-05 Merck & Co Inc Conjugates that can be used to treat benign prostate hyperplasia
EP0789032A2 (en) * 1996-02-01 1997-08-13 Bayer Corporation Method for preparing a monoclonal antibody that provides an equimolar response to free and complexed analyte in a monoclonal/polyclonal sandwich immunoassay
US6143509A (en) * 1996-02-06 2000-11-07 Abbott Laboratories Prostate specific antigen peptides and uses thereof
AU775537B2 (en) * 1996-04-26 2004-08-05 Children's Medical Center Corporation Non-invasive enzyme screen for tissue remodelling-associated conditions
US6811995B1 (en) 1996-04-26 2004-11-02 Children's Medical Center Corporation Non-invasive enzyme screen for cancer
AU2681997A (en) * 1996-04-26 1997-11-19 Children's Medical Center Corporation Non-invasive enzyme screen for tissue remodelling-associated conditions
WO1998010292A1 (en) * 1996-09-06 1998-03-12 Centocor, Inc. Monoclonal antibodies specific for prostate specific antigen and methods of detecting prostate specific antigen
DE19641560A1 (de) 1996-10-09 1998-04-16 Boehringer Mannheim Gmbh Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease
US6177404B1 (en) 1996-10-15 2001-01-23 Merck & Co., Inc. Conjugates useful in the treatment of benign prostatic hyperplasia
US6107103A (en) * 1996-10-15 2000-08-22 Procyon Bropharma Inc. Assay for PSP94 protein
US5840501A (en) * 1996-10-25 1998-11-24 Bayer Corporation Determination of cPSA
IL121659A (en) * 1996-10-25 2000-07-16 Bayer Ag Method for determining CPSA in a blood sample
US5856182A (en) * 1996-11-18 1999-01-05 Beckman Coulter, Inc. Monoclonal antibodies specific for the PSA-ACT complex
US6548260B1 (en) 1997-01-21 2003-04-15 Bayer Corporation Detection of PSA-α2-macroglobulin complex in a biological fluid
US6309816B1 (en) * 1997-04-16 2001-10-30 Horus Therapeutics, Inc. Methods for diagnosing cancer by measuring creatine kinase
DE19717436C2 (de) * 1997-04-25 2001-02-15 Biomac Gmbh Verfahren zur exakten Bestimmung von Prostata-spezifischem Antigen in Körperflüssigkeiten
US7288636B2 (en) * 1997-04-30 2007-10-30 Hybritech Incorporated Forms of prostate specific antigens and methods for their detection
ATE302413T1 (de) * 1997-05-14 2005-09-15 Biosite Diagnostics Inc Schnelle bestimmung des verhältnisses von biologischen molekülen
US5994085A (en) * 1997-08-26 1999-11-30 Cantor; Thomas L. Methods and devices for detecting non-complexed prostate specific antigen
US6649420B1 (en) 1997-08-26 2003-11-18 Thomas L. Cantor Methods and devices for detecting no-complexed prostate specific I antigen
US6300088B1 (en) 1997-11-24 2001-10-09 Duke University Method of detecting prostate specific antigen
DE19814915A1 (de) * 1998-04-03 1999-10-07 Roche Diagnostics Gmbh Immunologisches Verfahren zur Bestimmung von PSA
FI981186A7 (sv) 1998-05-28 1999-11-29 Stenman Ulf Haakan Ny immunbestämningsmetod och dess användning inom diagnostiken
FI981185A7 (sv) * 1998-05-28 1999-11-29 Stenman Ulf Haakan Ny diagnostisk metod
EP1100903A1 (en) * 1998-07-24 2001-05-23 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Pb 39, a gene dysregulated in prostate cancer, and uses thereof
US7226731B1 (en) 1998-07-24 2007-06-05 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services PB 39, a gene dysregulated in prostate cancer, and uses thereof
EP1104462B1 (en) * 1998-08-10 2007-01-03 Agensys, Inc. Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
AU774662B2 (en) 1999-04-20 2004-07-01 Target Discovery, Inc. Polypeptide fingerprinting methods, metabolic profiling, and bioinformatics database
US6423503B1 (en) * 1999-04-30 2002-07-23 Hybritech Incorporated Forms of free prostate-specific antigen (PSA) and their association with prostate tissues from prostate peripheral zone and transition zone
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
FR2807438B1 (fr) * 2000-04-10 2004-09-17 Bio Merieux Nouveaux anticorps reconnaissant specifiquement le psa libre inactif, et leurs applications
GB0012718D0 (en) * 2000-05-24 2000-07-19 Angeletti P Ist Richerche Bio Conjugates of aminodrugs
FR2810114B1 (fr) * 2000-06-13 2002-08-23 Bio Merieux Methode, procede, test immunologique et kit de diagnostic d'un adenocarcinome de la prostate ou d'une hypertrophie benigne de la prostate
CA2415923C (en) 2000-07-12 2011-10-25 Agensys, Inc. Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
EP1178317B1 (en) 2000-07-24 2004-11-10 Health Research, Inc. Method for detection of prostate specific membrane antigen in serum
US6379550B1 (en) 2000-07-24 2002-04-30 Health Research, Inc. Method for detecting PSA and its molecular forms using thiophilic gel
US6984494B2 (en) 2000-08-15 2006-01-10 Genentech, Inc. Analytical method
US6863892B2 (en) 2000-08-22 2005-03-08 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
EP2022797A3 (en) 2000-08-28 2011-11-09 Agensys, Inc. Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer
US6764825B1 (en) * 2000-10-13 2004-07-20 Tang J. Wang Methods and device for detecting prostate specific antigen (PSA)
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
AU2002318112B2 (en) 2001-04-10 2007-12-06 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
US20030191073A1 (en) 2001-11-07 2003-10-09 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
JP2005505271A (ja) 2001-09-06 2005-02-24 アジェンシス， インコーポレイテッド 癌の処置および検出において有用なｓｔｅａｐ−１と名称が与えられる核酸および対応するタンパク質
US7842498B2 (en) 2001-11-08 2010-11-30 Bio-Rad Laboratories, Inc. Hydrophobic surface chip
US7534580B2 (en) * 2002-05-01 2009-05-19 Ambrilia Biopharma Inc. PSP94 diagnostic reagents and assays
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
US20040176577A1 (en) * 2002-09-10 2004-09-09 Eva Rojer Immunoassays for specific determination of SCCA isoforms
AU2003296925A1 (en) * 2002-11-01 2004-06-07 Leucadia Technologies, Inc. Displacement sandwich immuno-pcr
EP1565200A4 (en) 2002-11-27 2009-06-24 Agensys Inc NUCLEIC ACID 24P4C12 AND CORRESPONDING PROTEIN FOR THE TREATMENT AND DETECTION OF CANCER
AU2004210975B2 (en) 2003-02-10 2008-04-10 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US20040229300A1 (en) * 2003-04-22 2004-11-18 Frederickson Christopher J. Zinc-based screening test and kit for early diagnosis of prostate cancer
ATE541052T1 (de) 2003-05-30 2012-01-15 Agensys Inc Varianten des prostata-stammzellen-antigens (psca) und teilsequenzen davon
JP4651663B2 (ja) 2004-05-28 2011-03-16 アジェンシス，インコーポレイテッド Ｐｓｃａタンパク質に結合する抗体および関連分子
DE102004027429B4 (de) 2004-06-04 2018-09-13 Siemens Healthcare Diagnostics Gmbh Verfahren zur Anwendung von auf Markerwerten basierenden Dichtekarten bei der Diagnose von Patienten mit Krankheiten insbesondere von Tumoren
US8338579B2 (en) 2004-11-03 2012-12-25 Iris Molecular Diagnostics, Inc. Homogeneous analyte detection
JP5037350B2 (ja) * 2004-11-03 2012-09-26 アイリス モレキュラー ダイアグノスティクス， インコーポレイテッド 親和性分離のための微粒気泡
US8663600B2 (en) * 2005-02-17 2014-03-04 Diaprost Ab Diagnosis of prostate cancer
US20080125582A1 (en) * 2006-10-13 2008-05-29 Bio-Rad Laboratories, Inc. Methods and compositions for stabilizing prostate specific antigen
US20090062624A1 (en) * 2007-04-26 2009-03-05 Thomas Neville Methods and systems of delivering a probability of a medical condition
US8202492B2 (en) 2007-05-04 2012-06-19 Opko Diagnostics, Llc Fluidic connectors and microfluidic systems
WO2009029550A2 (en) * 2007-08-24 2009-03-05 Singulex, Inc. Highly sensitive system and methods for analysis of prostate specific antigen (psa)
US8362325B2 (en) 2007-10-03 2013-01-29 Ceres, Inc. Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics
EP2252893B1 (en) * 2008-02-21 2013-10-23 Iris International, Inc. Method for early determination of recurrence after therapy for prostate cancer
GB2464032A (en) * 2008-05-15 2010-04-07 Soar Biodynamics Ltd Methods and systems for integrated health systems
WO2010075446A1 (en) * 2008-12-23 2010-07-01 Soar Biodynamics, Ltd. Methods and systems for prostate health monitoring
US20100173791A1 (en) 2009-01-05 2010-07-08 Bio-Rad Laboratories, Inc. Process design using mass spectrometry
DE202010018623U1 (de) 2009-02-02 2018-12-07 Opko Diagnostics, Llc Strukturen zur Steuerung der Lichtwechselwirkung mit mikrofluidischen Vorrichtungen
EP2239675A1 (en) 2009-04-07 2010-10-13 BIOCRATES Life Sciences AG Method for in vitro diagnosing a complex disease
CN102346536A (zh) * 2010-07-29 2012-02-08 元太科技工业股份有限公司 省电触控电子书
EP2698633B1 (en) 2011-03-28 2017-10-11 Sekisui Medical Co., Ltd. Psa assay method and reagent therefor
CN104040341B (zh) 2011-10-25 2016-12-28 斯隆－凯特林纪念癌症中心 用于前列腺癌的诊断、预测和治疗的游离psa抗体
US10323256B2 (en) 2011-12-09 2019-06-18 Ceres, Inc. Transgenic plants having altered biomass composition
KR101933752B1 (ko) 2012-03-05 2018-12-28 오와이 아크틱 파트너스 에이비 전립선 암의 위험성 및 전립선 부피를 예측하는 방법 및 장치
CA2944001C (en) 2014-03-28 2023-08-15 Opko Diagnostics, Llc Compositions and methods related to diagnosis of prostate cancer
US12326453B2 (en) 2014-03-28 2025-06-10 Opko Diagnostics, Llc Compositions and methods for active surveillance of prostate cancer
JP6749337B2 (ja) 2015-03-27 2020-09-02 オプコ・ダイアグノスティクス・リミテッド・ライアビリティ・カンパニーＯｐｋｏ Ｄｉａｇｎｏｓｔｉｃｓ，Ｌｌｃ 前立腺抗原標準およびその使用
CN108802392A (zh) * 2018-08-29 2018-11-13 上海市东方医院 一种用于诊断前列腺癌的层析试纸条及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
JPS57500169A (sv) * 1979-12-28 1982-01-28
US4690890A (en) * 1984-04-04 1987-09-01 Cetus Corporation Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
IE62580B1 (en) * 1985-03-29 1995-02-08 Hybritech Inc Processes for the stabilization of prostate specific antigen in natural matrices
JPH0690203B2 (ja) * 1985-08-23 1994-11-14 中外製薬株式会社 前立腺特異抗原とα▲下１▼−アンチトリプシン複合体の定量方法
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5599686A (en) * 1994-06-28 1997-02-04 Merck & Co., Inc. Peptides

Also Published As

Publication number Publication date
ATE134448T1 (de) 1996-03-15
WO1992001936A1 (en) 1992-02-06
ES2070107T5 (es) 2004-05-16
ES2070107T1 (es) 1995-06-01
JPH06502719A (ja) 1994-03-24
EP0540573A1 (en) 1993-05-12
EP0540573B2 (en) 2003-11-19
DK0540573T3 (da) 1996-04-09
US20020123616A1 (en) 2002-09-05
US5939533A (en) 1999-08-17
DE69117292D1 (de) 1996-03-28
DE69117292T3 (de) 2004-06-03
DK0540573T4 (da) 2004-04-05
US5501983A (en) 1996-03-26
JP2669566B2 (ja) 1997-10-29
EP0540573B1 (en) 1996-02-21
DE69117292T2 (de) 1996-07-18
GR3019888T3 (en) 1996-08-31
US5912158A (en) 1999-06-15
DE540573T1 (de) 1995-09-28
ES2070107T3 (es) 1996-04-16

Similar Documents

Publication Publication Date Title
SE9002480D0 (sv) Assay of free and complexed prostate-specific antigen
Kuriyama et al. Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens
ATE101202T1 (de) Antikoerper.
DK0914155T3 (da) Monoklonale antistoffer, der er spepcifikke for det ekstracellulære domæne af prostataspecifikt membran-antigen
NO974534L (no) Bestemmelse av cPSA
ES8507692A1 (es) Un procedimiento para preparar un trazador para uso en ensayo no isotopico
Watanabe et al. Enzyme immunoassay for human ferritin.
FI922017A0 (fi) Immunbestaemningar och monoklonala antikroppar foer protrombinaktiveringspeptider och degradations- produkter av dessa.
GR3005971T3 (sv)
ES464929A1 (es) Metodo mejorado de ensayo inmunologico de enlace con enzima para la deteccion y determinacion de antigenos
DE69529106D1 (de) Monoklonaler Antikörper gegen denThrombin-Antithrombin III-Komplex und dessen Verwendung in Immunoassays
IL100527A (en) Prescreening of prostate cancer by serum prostatic specific antigen
IT1264083B1 (it) Procedimento per la produzione in piante di anticorpi ingegnerizzati, anticorpi prodotti e loro uso in diagnosi e terapia.
Bogdanowicz et al. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia
ES2168378T3 (es) Determinacion de tripsinogeno-2 libre y en forma de complejo.
JPS55135752A (en) Determination method of immunogloblin e in human blood by enzyme immunity measuring method
YU164090A (sh) Postopek za dokazovanje analitov
Durrant et al. Development of an ELISA to detect early local relapse of colorectal cancer
KR850003169A (ko) 염기성 태아단백질의 측정방법 및 시약
FI922480A0 (fi) Diagnostiskt foerfarande.
WO1990008956A1 (en) Detection of human tissue factor activator
JPS56150356A (en) Immunologic measuring method